{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:45:40Z","timestamp":1794257140520,"version":"4.9.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1111\/1469-0691.12641","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T13:42:38Z","timestamp":1396878158000},"page":"89-101","source":"Crossref","is-referenced-by-count":107,"special_numbering":"S7","title":["Mycobacterial infections in solid organ transplant recipients"],"prefix":"10.1016","volume":"20","author":[{"given":"Y.","family":"Meije","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Piersimoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Torre-Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G","family":"Dilektasli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12641_bib1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/00007890-199705150-00015","article-title":"Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA","volume":"63","author":"Aguado","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib2","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib3","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1111\/tri.12102","article-title":"European survey on the management of tuberculosis in solid-organ transplant recipients and candidates","volume":"26","author":"Boillat-Blanco","year":"2013","journal-title":"Transpl Int"},{"key":"10.1111\/1469-0691.12641_bib4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S1473-3099(13)70276-7","article-title":"Tuberculosis rates unacceptably high in UK cities","volume":"13","author":"Kirby","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib7","author":"WHO"},{"key":"10.1111\/1469-0691.12641_bib8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.transproceed.2006.03.029","article-title":"Mycobacterium tuberculosis infection in renal transplant recipients","volume":"38","author":"Ergun","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12641_bib9","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1093\/ndt\/gfr156","article-title":"Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years","volume":"26","author":"Canet","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/1469-0691.12641_bib10","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.transproceed.2012.09.060","article-title":"Clinical features and outcomes of tuberculosis in solid organ transplant recipients","volume":"44","author":"Bodro","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12641_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.TP.0000147784.53188.DC","article-title":"Tuberculosis in lung transplant recipients","volume":"79","author":"Bravo","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib13","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1016\/j.transproceed.2005.09.144","article-title":"Pulmonary tuberculosis in lung and heart-lung transplantation: fifteen years of experience in a single center in Spain","volume":"37","author":"Morales","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12641_bib14","first-page":"1909","article-title":"Tuberculosis in renal allograft recipients","volume":"24","author":"Koselj","year":"1992","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12641_bib15","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/427692","article-title":"Mycobacterium tuberculosis infection in recipients of solid organ transplants","volume":"40","author":"Munoz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/TP.0b013e31828719c8","article-title":"Mycobacterium Tuberculosis-Associated Immune Reconstitution Syndrome in Solid-Organ Transplant Recipients","volume":"95","author":"Sun","year":"2013","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"10.1111\/1469-0691.12641_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0213-005X(12)70079-4","article-title":"Infection prevention in solid organ transplantation","volume":"30","author":"Gavalda","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/1469-0691.12641_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1473-3099(06)70628-4","article-title":"International standards for tuberculosis care","volume":"6","author":"Hopewell","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib21","first-page":"1","article-title":"Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection \u2013 United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/1469-0691.12641_bib24","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/TP.0b013e3182907073","article-title":"Contribution of interferon-gamma release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation","volume":"95","author":"Hadaya","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s15010-012-0291-0","article-title":"Comparison of the tuberculin skin test and interferon-gamma release assay for the diagnosis of latent tuberculosis infection before kidney transplantation","volume":"41","author":"Kim","year":"2013","journal-title":"Infection"},{"key":"10.1111\/1469-0691.12641_bib26","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients","volume":"11","author":"Kim","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12641_bib27","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2007.02011.x","article-title":"Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation","volume":"7","author":"Manuel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12641_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3062.2011.00666.x","article-title":"Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study","volume":"14","author":"Theodoropoulos","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib30","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1600-6143.2011.03626.x","article-title":"The current state of tuberculosis in solid organ transplantation: three principles for optimal management","volume":"11","author":"Doblas","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12641_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/TP.0b013e3182977adf","article-title":"Incidence of tuberculosis in deceased-organ donors and transmission risk to recipients in Spain","volume":"96","author":"Coll","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib32","unstructured":"National Institute for Health and Clinical Excelence (NICE). Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE Clinical Guideline 117, 2011."},{"key":"10.1111\/1469-0691.12641_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.autrev.2008.07.011","article-title":"Screening for tuberculosis infection prior to initiation of anti-TNF therapy","volume":"8","author":"Lalvani","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"Suppl 4","key":"10.1111\/1469-0691.12641_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajt.12100","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation","volume":"13","author":"Subramanian","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12641_bib35","series-title":"Infections in solid organ transplant recipients","first-page":"5","article-title":"Cumitech 45","author":"Alangaden","year":"2008"},{"key":"10.1111\/1469-0691.12641_bib36","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib37","series-title":"Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes. CLSI document M24-A2","author":"Clinical and Laboratory Standard Institute","year":"2011"},{"key":"10.1111\/1469-0691.12641_bib38","series-title":"Laboratory detection and identification of mycobacteria. M48-A","author":"Clinical and Laboratory Standard Institute","year":"2008"},{"key":"10.1111\/1469-0691.12641_bib39","first-page":"7","article-title":"Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis","volume":"58","author":"Centers for Disease Control Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/1469-0691.12641_bib40","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00061808","article-title":"GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis","volume":"32","author":"Ling","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1111\/1469-0691.12641_bib41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/1469-0691.12641_bib42","first-page":"1","article-title":"American Thoracic Society","volume":"49","author":"Targeted tuberculin testing and treatment of latent tuberculosis infection","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/1469-0691.12641_bib43","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/00007890-200211270-00006","article-title":"Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area","volume":"74","author":"Benito","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib44","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199457110-00029","article-title":"A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients","volume":"57","author":"John","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-3062.2005.00103.x","article-title":"Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy","volume":"7","author":"Vikrant","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11255-004-6251-6","article-title":"Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient","volume":"36","author":"Agarwal","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"10.1111\/1469-0691.12641_bib47","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/ndt\/gfp489","article-title":"Use of isoniazid chemoprophylaxis in renal transplant recipients","volume":"25","author":"Naqvi","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/1469-0691.12641_bib48","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/TP.0b013e3181ecea8d","article-title":"Tuberculosis in renal transplant recipients: the evidence for prophylaxis","volume":"90","author":"Currie","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1399-3062.2004.00050.x","article-title":"Long-term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients","volume":"6","author":"Lui","year":"2004","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib50","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","volume":"161","author":"Targeted tuberculin testing and treatment of latent tuberculosis infection","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/1469-0691.12641_bib51","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/1469-0691.12641_bib52","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/thx.2009.125054","article-title":"Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB","volume":"65","author":"Aspler","year":"2010","journal-title":"Thorax"},{"key":"10.1111\/1469-0691.12641_bib53","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/01.tp.0000266578.45634.4f","article-title":"Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period","volume":"83","author":"Jahng","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib54","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12641_bib55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/TP.0b013e3182a94a2f","article-title":"Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates","volume":"97","author":"de Castilla","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib56","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/314007","article-title":"Practice guidelines for the treatment of tuberculosis","volume":"31","author":"Horsburgh","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib57","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1086\/375072","article-title":"Severe hepatotoxicity associated with rifampin-pyrazinamide preventative therapy requiring transplantation in an individual at low risk for hepatotoxicity","volume":"36","author":"Kunimoto","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib58","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s11908-012-0293-1","article-title":"Tuberculosis in transplantation: diagnosis, prevention, and treatment","volume":"14","author":"Kirsch","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"10.1111\/1469-0691.12641_bib59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1399-0012.2006.00630.x","article-title":"Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis","volume":"21","author":"Nagai","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1111\/1469-0691.12641_bib60","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/lt.23480","article-title":"Chemoprophylaxis with isoniazid in liver transplant recipients","volume":"18","author":"Fabrega","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12641_bib61","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/lt.22203","article-title":"Detection and management of latent tuberculosis in liver transplant patients","volume":"17","author":"Jafri","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12641_bib62","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00007890-200209270-00029","article-title":"Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis","volume":"74","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.transproceed.2010.12.033","article-title":"Tuberculosis in liver transplant recipients: prophylaxis in an endemic area","volume":"43","author":"Agoglia","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12641_bib65","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/lt.21709","article-title":"Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data","volume":"15","author":"Holty","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12641_bib66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MOT.0b013e3283324dfc","article-title":"Mycobacterium tuberculosis infection in transplant recipients: early diagnosis and treatment of resistant tuberculosis","volume":"14","author":"Holty","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/1469-0691.12641_bib67","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/lt.22133","article-title":"Mycobacterium tuberculosis infection in liver transplantation","volume":"16","author":"Yehia","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12641_bib68","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1111\/j.1600-6143.2012.04205.x","article-title":"Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report","volume":"12","author":"Morris","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12641_bib69","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1358\/mf.2000.22.8.802278","article-title":"Isoniazid does not affect bioavailability of cyclosporine in renal transplant recipients","volume":"22","author":"Sud","year":"2000","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1111\/1469-0691.12641_bib70","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.tp.0000188689.41785.d8","article-title":"Screening for tuberculosis in the study of the living renal donor in a developing country","volume":"81","author":"Hernandez-Hernandez","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib71","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.00000712","article-title":"The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement","volume":"40","author":"Bumbacea","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1111\/1469-0691.12641_bib72","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0213-005X(02)72841-3","article-title":"Infectious disease assessment in solid organ transplant candidates","volume":"20","author":"Ayats-Ardite","year":"2002","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"Suppl 4","key":"10.1111\/1469-0691.12641_bib73","first-page":"39","article-title":"European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis","volume":"17","author":"EBPG Expert Group on Renal Transplantation","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/1469-0691.12641_bib74","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00007890-199010000-00014","article-title":"Successful use of rifampicin in the treatment of tuberculosis in renal transplant patients immunosuppressed with cyclosporine","volume":"50","author":"Al-Sulaiman","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib75","first-page":"924","article-title":"Tuberculosis in transplanted lungs","volume":"12","author":"Dromer","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12641_bib76","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.1976.03270180034016","article-title":"Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function","volume":"236","author":"Buffington","year":"1976","journal-title":"JAMA"},{"key":"10.1111\/1469-0691.12641_bib80","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00007890-198503000-00022","article-title":"Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin","volume":"39","author":"Modry","year":"1985","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib81","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mehy.2005.07.007","article-title":"Electromagnetic field effect on separation of nucleotide sequences and unwinding of a double helix during DNA replication","volume":"66","author":"Cheng","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1111\/1469-0691.12641_bib82","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1345\/aph.19069","article-title":"Renal allograft dysfunction associated with rifampin-tacrolimus interaction","volume":"34","author":"Chenhsu","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1111\/1469-0691.12641_bib84","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3349\/ymj.2004.45.5.865","article-title":"Clinical outcomes of tuberculosis in renal transplant recipients","volume":"45","author":"Park","year":"2004","journal-title":"Yonsei Med J"},{"key":"10.1111\/1469-0691.12641_bib85","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1478-3231.2006.01397.x","article-title":"Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation","volume":"27","author":"Chan","year":"2007","journal-title":"Liver Int"},{"key":"10.1111\/1469-0691.12641_bib86","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/S0272-6386(04)00947-3","article-title":"Treatment of tuberculosis with rifabutin in a renal transplant recipient","volume":"44","author":"Lopez-Montes","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/1469-0691.12641_bib87","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S1053-2498(02)01189-0","article-title":"Multidrug-resistant tuberculosis in a lung transplant recipient","volume":"22","author":"Lee","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/1469-0691.12641_bib89","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/clinids\/21.2.398","article-title":"Tuberculosis in heart transplant recipients","volume":"21","author":"Munoz","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib90","first-page":"112","article-title":"Drug interaction between rifampicin and sirolimus in transplant patients","volume":"22","author":"Ngo","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1111\/1469-0691.12641_bib92","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MAJ.0b013e31812f5a4e","article-title":"Clinical features and outcome of tuberculosis in solid organ transplant recipients","volume":"334","author":"Hsu","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1111\/1469-0691.12641_bib93","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/1469-0691.12641_bib94","first-page":"364","article-title":"Isoniazid hepatotoxicity after orthotopic liver transplantation","volume":"63","author":"Schluger","year":"1996","journal-title":"Mt Sinai J Med"},{"key":"10.1111\/1469-0691.12641_bib95","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00007890-200001150-00013","article-title":"Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens","volume":"69","author":"Meyers","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib96","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00007890-199601270-00008","article-title":"The high incidence of tuberculosis among renal transplant recipients in India","volume":"61","author":"Sakhuja","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12641_bib97","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1023\/A:1025693521582","article-title":"Tuberculosis in renal transplant recipients: rifampicin sparing treatment protocol","volume":"34","author":"Vachharajani","year":"2002","journal-title":"Int Urol Nephrol"},{"key":"10.1111\/1469-0691.12641_bib98","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1086\/598929","article-title":"Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens","volume":"48","author":"Ho","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib99","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.transproceed.2011.12.065","article-title":"Safety and efficacy of a quinolone-based regimen for treatment of tuberculosis in renal transplant recipients","volume":"44","author":"Yoon","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12641_bib100","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1046\/j.1523-1755.1999.00746.x","article-title":"Successful management of pulmonary tuberculosis in renal allograft recipients in a single center","volume":"56","author":"Jha","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/1469-0691.12641_bib101","doi-asserted-by":"crossref","unstructured":"Jindani A, Hatherill M, Charalambous S et al. A multicentre randomized clinical trial to evaluate high-dose Rifapentine with a Quinolone for treatment of pulmonary TB: The RIFAQUIN Trial. 20th Conference on Retroviruses and Opportunistic Infections (CROI); 2013; March 3-6; Atlanta. Abstract 147LB.","DOI":"10.1186\/ISRCTN44153044"},{"key":"10.1111\/1469-0691.12641_bib102","unstructured":"Merle C, Fielding K, Lapujade O et al. A randomized controlled trial of 4-month Gatifloxacin-containing regimen vs. standard 6-month regimen for treating drug-susceptible pulmonary tuberculosis: main efficacy and safety results of the OFLOTUB Trial. 44th Union World Conference on Lung Health; 2013; October 30-November 3; Paris. Session 39 (late breaker)."},{"key":"10.1111\/1469-0691.12641_bib103","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1128\/AAC.00695-11","article-title":"Current prospects for the fluoroquinolones as first-line tuberculosis therapy","volume":"55","author":"Takiff","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12641_bib104","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jac\/dkr205","article-title":"Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania","volume":"66","author":"van den Boogaard","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12641_bib105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1592\/phco.22.9.701.34065","article-title":"Limited tolerability of levofloxacin and pyrazinamide for multidrug-resistant tuberculosis prophylaxis in a solid organ transplant population","volume":"22","author":"Lou","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1111\/1469-0691.12641_bib106","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jac\/dki148","article-title":"Linezolid for the treatment of multidrug-resistant tuberculosis","volume":"56","author":"Fortun","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12641_bib107","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-150-11-200906020-00004","article-title":"Predictors of extensively drug-resistant pulmonary tuberculosis","volume":"150","author":"Kliiman","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/1469-0691.12641_bib108","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3201\/eid1004.030667","article-title":"Mycobacterium tuberculosis complex drug resistance in Italy","volume":"10","author":"Migliori","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib109","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1440-1843.2008.01360.x","article-title":"Lung transplantation in Hong Kong: 12 years of experience","volume":"13","author":"Wong","year":"2008","journal-title":"Respirology"},{"key":"10.1111\/1469-0691.12641_bib111","first-page":"79","article-title":"Multidrug resistant tuberculosis following lung transplantation: treatment with pulmonary resection","volume":"59","author":"Shitrit","year":"2004","journal-title":"Thorax"},{"key":"10.1111\/1469-0691.12641_bib112","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1164\/rccm.200308-1159OC","article-title":"Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis","volume":"169","author":"Chan","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/1469-0691.12641_bib113","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/09031936.00073611","article-title":"WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update","volume":"38","author":"Falzon","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1111\/1469-0691.12641_bib114","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/1469-0691.12641_bib115","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/420746","article-title":"Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients","volume":"38","author":"Doucette","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib116","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MOT.0b013e3283327cd6","article-title":"Nontuberculous mycobacterial disease in transplant recipients: early diagnosis and treatment","volume":"14","author":"Daley","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/1469-0691.12641_bib117","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10096-011-1329-4","article-title":"Nontuberculous mycobacteria infection in solid organ transplant recipients","volume":"31","author":"Piersimoni","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 4","key":"10.1111\/1469-0691.12641_bib118","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1111\/j.1600-6143.2009.02895.x","article-title":"Nontuberculous mycobacteria in solid organ transplant recipients","volume":"9","author":"Dorman","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12641_bib119","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/thx.2005.049247","article-title":"Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation","volume":"61","author":"Chalermskulrat","year":"2006","journal-title":"Thorax"},{"key":"10.1111\/1469-0691.12641_bib120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.healun.2011.02.007","article-title":"Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality","volume":"30","author":"Huang","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 4","key":"10.1111\/1469-0691.12641_bib121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/ajt.12101","article-title":"Nontuberculous mycobacterial infections in solid organ transplantation","volume":"13","author":"Keating","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12641_bib122","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/CMR.05030-11","article-title":"Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria","volume":"25","author":"Brown-Elliott","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12641_bib123","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/504381","article-title":"Infections due to rapidly growing mycobacteria","volume":"42","author":"De Groote","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib5","first-page":"277","article-title":"Tuberculosis in Poland in 2011","volume":"67","author":"Korzeniewska-Kosela","year":"2013","journal-title":"Przegl Epidemiol"},{"key":"10.1111\/1469-0691.12641_bib6","first-page":"72","article-title":"Prudent optimism and the evolution of the main indicators of endemic tuberculosis in Romania in 2012","volume":"62","author":"Popescu","year":"2013","journal-title":"Pneumologia"},{"key":"10.1111\/1469-0691.12641_bib12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1053-2498(00)00163-7","article-title":"Isoniazid prophylaxis in lung transplantation","volume":"19","author":"Roman","year":"2000","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 2","key":"10.1111\/1469-0691.12641_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0213-005X(12)70080-0","article-title":"Tuberculosis in solid organ transplant patients","volume":"30","author":"Doblas","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/1469-0691.12641_bib22","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1378\/chest.10-0366","article-title":"Recent advances in testing for latent TB","volume":"138","author":"Schluger","year":"2010","journal-title":"Chest"},{"key":"10.1111\/1469-0691.12641_bib23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/cid\/cir068","article-title":"Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection","volume":"52","author":"Herrera","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1378\/chest.08-2575","article-title":"Performance of tests for latent tuberculosis in different groups of immunocompromised patients","volume":"136","author":"Richeldi","year":"2009","journal-title":"Chest"},{"key":"10.1111\/1469-0691.12641_bib63","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.transproceed.2012.07.035","article-title":"Is isoniazid safe for liver transplant candidates with latent tuberculosis?","volume":"44","author":"Stucchi","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/1469-0691.12641_bib77","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1086\/516138","article-title":"Interactions between tacrolimus and antimicrobial agents","volume":"25","author":"Paterson","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib78","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/bmj.286.6369.923","article-title":"Rifampicin reduces effectiveness and bioavailability of prednisolone","volume":"286","author":"McAllister","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1111\/1469-0691.12641_bib79","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/651686","article-title":"Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis","volume":"50","author":"Khan","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib83","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1399-3062.2012.00721.x","article-title":"Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients","volume":"14","author":"Ha","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12641_bib88","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/j.1875-9114.1991.tb03603.x","article-title":"Rifampin and ansamycin interactions with cyclosporine after renal transplantation","volume":"11","author":"Vandevelde","year":"1991","journal-title":"Pharmacotherapy"},{"key":"10.1111\/1469-0691.12641_bib91","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1111\/j.1432-2277.2012.01561.x","article-title":"Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis","volume":"25","author":"Lefeuvre","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/1469-0691.12641_bib110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s001470050147","article-title":"Fatal primary multidrug-resistant tuberculosis in a heart transplant recipient","volume":"11","author":"Di Perri","year":"1998","journal-title":"Transpl Int"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14605036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14605036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T18:46:08Z","timestamp":1716662768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14605036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":123,"alternative-id":["S1198743X14605036"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12641","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}